SKN | Jones Ventures INTL Acquisition1 Prices $200 Million SPAC IPO to Target High-Growth Industries
Jones Ventures INTL Acquisition1 has successfully priced its $200 million IPO, joining the growing pipeline of special purpose acquisition companies seeking opportunities in innovative...
SKN | Attovia Therapeutics Files for $100 Million IPO to Advance Pipeline for Immune-Mediated Diseases
Key Points:
• Attovia Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) to raise up to $100 million through an initial public...
SKN | Abbott Laboratories (NYSE: ABT) Heads Into Q2 Earnings as Medical Device Growth Remains in Focus
Abbott Laboratories (NYSE: ABT) is set to report its second-quarter 2026 earnings on July 16, 2026, with investors closely watching whether the healthcare giant...
SKN | Columbia ETF Trust I Expands Market Presence as Demand for Active ETF Strategies Accelerates
Columbia ETF Trust I is preparing for its latest exchange-traded fund market debut as investors continue shifting toward flexible investment products that combine active...
SKN | Qualivian Focus Fund ETF Targets Investors Seeking Concentrated Active Market Exposure
Qualivian Focus Fund ETF is entering the exchange-traded fund market as demand for actively managed investment strategies continues to expand among investors seeking alternatives...